3SBio Inc.
3SBio Inc. (TRSBF) Financial Performance & Income Statement Overview
Review 3SBio Inc. (TRSBF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
3SBio Inc. (TRSBF) Income Statement & Financial Overview
Review 3SBio Inc. TRSBF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $4.72B | $4.39B | $2.02B | $2.02B |
| Cost of Revenue | $687.55M | $592.05M | $296.010M | $296.010M |
| Gross Profit | $4.03B | $3.80B | $1.72B | $1.72B |
| Gross Profit Ratio | $0.85 | $0.87 | $0.85 | $0.85 |
| R&D Expenses | $850.30M | $476.23M | $244.10M | $244.10M |
| SG&A Expenses | $2.06B | $1.80B | $948.94M | $948.94M |
| Operating Expenses | $2.91B | $2.27B | $1.19B | $1.28B |
| Total Costs & Expenses | $3.60B | $2.86B | $1.49B | $1.57B |
| Interest Income | $0.00 | $0.00 | $51.12M | $51.12M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $139.04M | $176.12M | $76.86M | $76.86M |
| EBITDA | $1.25B | $1.67B | $384.51M | $384.51M |
| EBITDA Ratio | $0.27 | $0.38 | $0.19 | $0.19 |
| Operating Income | $1.12B | $1.53B | $527.005M | $307.65M |
| Operating Income Ratio | $0.24 | $0.35 | $0.26 | $0.15 |
| Other Income/Expenses (Net) | $173.66M | -$104.12M | -$134.81M | -$134.81M |
| Income Before Tax | $1.30B | $1.42B | $392.20M | $392.20M |
| Income Before Tax Ratio | $0.27 | $0.32 | $0.19 | $0.19 |
| Income Tax Expense | $186.25M | $314.28M | $92.28M | $92.28M |
| Net Income | $1.000B | $1.09B | $284.33M | $284.33M |
| Net Income Ratio | $0.21 | $0.25 | $0.14 | $0.14 |
| EPS | $0.41 | $0.45 | $0.12 | $0.12 |
| Diluted EPS | $0.40 | $0.45 | $0.12 | $0.12 |
| Weighted Avg Shares Outstanding | $2.50B | $2.43B | $2.44B | $2.44B |
| Weighted Avg Shares Outstanding (Diluted) | $2.50B | $2.43B | $2.44B | $2.44B |
Financial performance has remained strong, with revenue growing from $2.02B in Q3 2023 to $4.72B in Q4 2024. Gross profit continued to perform well, with margins at 85% in the latest quarter. Operating income reached $1.12B in Q4 2024, holding a steady 24% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.25B. Net income dropped to $1.000B, keeping EPS at $0.41. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan